Detalles de la búsqueda
1.
Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature.
Gynecol Oncol
; 161(1): 70-77, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33419612
2.
Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Gynecol Oncol
; 161(2): 521-526, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33712278
3.
Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option.
J Obstet Gynaecol Res
; 47(1): 44-51, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33103312
4.
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
PLoS One
; 18(12): e0294448, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38039311
5.
Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesia.
Front Surg
; 10: 1279907, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026485
6.
Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series.
Gynecol Oncol Rep
; 36: 100741, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748383
7.
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.
Oncotarget
; 8(51): 88410-88420, 2017 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29179445
8.
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
JAMA Oncol
; 1(4): 486-94, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26181259
Resultados
1 -
8
de 8
1
Próxima >
>>